OrganTech Grants Domestic Manufacturing License for Cell-Derived Components, Including the 'Third Cell'

OrganTech, a biotech company committed to creating innovative medical technologies to improve health and quality of life (QOL), announces that it has granted a domestic manufacturing license for cell-derived components of hair follicle-derived cells—specifically the 'third cell' (hair follicle regeneration-supporting cell) and dermal papilla cells—to Kojin Bio.

This marks the second business collaboration between OrganTech and Kojin Bio, following their joint project on three-dimensional artificial skin. Hair follicle epithelial stem cells and dermal papilla cells play crucial roles in the regeneration of hair follicle organs. In February 2026, OrganTech became the first in the world to discover the 'third cell,' known as the 'hair follicle regeneration-supporting cell,' which induces hair follicle organ regeneration. Meanwhile, Kojin Bio has been selling high-performance culture media that enables the cultivation of dermal papilla cells and hair follicle regeneration-supporting cells derived from hair follicles.

OrganTech is licensing the manufacturing rights for these cell-derived components within Japan to Kojin Bio. By utilizing Kojin Bio's proprietary cell culture media and processing technologies, OrganTech aims to expand its hair and skin-related businesses.

OrganTech positions this manufacturing license grant to Kojin Bio as a key initiative in its hair-related cell business. Moving forward, the company intends to accelerate the research and development of hair regenerative medicine (including cell transfer therapy, hair follicle primordial transplantation, and regenerated hair follicle transplantation) and diverse products utilizing cell-derived components, in collaboration with medical institutions and various partners.

In the fields of hair and skin, OrganTech aims to contribute to a society that ensures safety, security, and high QOL by addressing various healthcare challenges such as alopecia, skin diseases, and aging through the accumulation of scientific evidence and technological development.